Multiple Novel Ceftazidime-Avibactam-Resistant Variants of bla KPC-2 -Positive Klebsiella pneumoniae in Two Patients
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multiple Novel Ceftazidime-Avibactam-Resistant Variants of
bla
KPC-2
-Positive Klebsiella pneumoniae in Two Patients
Authors
Keywords
-
Journal
Microbiology Spectrum
Volume -, Issue -, Pages -
Publisher
American Society for Microbiology
Online
2022-05-19
DOI
10.1128/spectrum.01714-21
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of Four Carbapenemase Detection Methods for bla KPC-2 Variants
- (2022) Li Ding et al. Microbiology Spectrum
- Evaluation of the Immunochromatographic NG-Test Carba 5, RESIST-5 O.O.K.N.V., and IMP K-SeT for Rapid Detection of KPC-, NDM-, IMP-, VIM-type, and OXA-48-like Carbapenemase Among Enterobacterales
- (2021) Renru Han et al. Frontiers in Microbiology
- Continuous Evolution: Perspective on the Epidemiology of Carbapenemase Resistance Among Enterobacterales and Other Gram-Negative Bacteria
- (2021) Glen T. Hansen Infectious Diseases and Therapy
- KPC-12 with a L169M substitution in the Ω loop has reduced carbapenemase activity
- (2021) Jiayuan Qin et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Characterization of KPC-82, a KPC-2 variant conferring resistance to ceftazidime-avibactam in a carbapenem non-susceptible, clinical isolate of Citrobacter koseri
- (2021) Francois Lebreton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evolutionary Trajectories toward Ceftazidime-Avibactam Resistance in Klebsiella pneumoniae Clinical Isolates
- (2021) Alessandra Carattoli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of a KPC Variant Conferring Resistance to Ceftazidime-Avibactam in a Widespread ST11 Carbapenem-Resistant Klebsiella pneumoniae Clone in China
- (2021) Xi Li et al. Frontiers in Microbiology
- Update on the role of ceftazidime-avibactam in the management of carbapenemase-producing Enterobacterales
- (2020) Beatriz Dietl et al. Future Microbiology
- Genetic diversity and in vitro activity of ceftazidime/avibactam and aztreonam/avibactam against imipenem-resistant Enterobacteriaceae isolates in Southwest China: a single-centre study
- (2020) Jie Wei et al. Journal of Global Antimicrobial Resistance
- Emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in KPC-2-producing Klebsiella pneumoniae of sequence type 39 during treatment
- (2020) Irene Galani et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Phenotypic and genotypic analysis of KPC-51 and KPC-52, two novel KPC-2 variants conferring resistance to ceftazidime/avibactam in the KPC-producing Klebsiella pneumoniae ST11 clone background
- (2020) Lingxiao Sun et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- RESIST-5 O.O.K.N.V. and NG-Test Carba 5 assays for the rapid detection of carbapenemase-producing Enterobacterales from positive blood cultures: a comparative study
- (2020) G. Bianco et al. JOURNAL OF HOSPITAL INFECTION
- Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Enterobacteriaceae Isolated From Adult and Children Patients in China
- (2020) Renru Han et al. Frontiers in Cellular and Infection Microbiology
- Reduced Ceftazidime-Avibactam Susceptibility in KPC-Producing Klebsiella pneumoniae From Patients Without Ceftazidime-Avibactam Use History – A Multicenter Study in China
- (2020) Xiaoyan Cui et al. Frontiers in Microbiology
- Characterization of the Genetic Background of KPC-2-Producing Klebsiella pneumoniae with Insertion Elements Disrupting the ompK36 Porin Gene
- (2020) Lii-Tzu Wu et al. Microbial Drug Resistance
- A Novel KPC Variant KPC-55 in Klebsiella pneumoniae ST307 of Reinforced Meropenem-Hydrolyzing Activity
- (2020) Eun-Jeong Yoon et al. Frontiers in Microbiology
- Emergence and Recovery of Ceftazidime-avibactam Resistance in blaKPC-33-Harboring Klebsiella pneumoniae Sequence Type 11 Isolates in China
- (2020) Qingyu Shi et al. CLINICAL INFECTIOUS DISEASES
- Convergence of carbapenem resistance and hypervirulence in a highly-transmissible ST11 clone of K. pneumoniae: An epidemiological, genomic and functional study
- (2020) Ping Li et al. Virulence
- Co-occurrence of three different plasmids in an extensively drug-resistant hypervirulent Klebsiella pneumoniae isolate causing urinary tract infection
- (2020) Xiaokui Zhu et al. Journal of Global Antimicrobial Resistance
- In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa: Results from a Multicenter Study in China, 2017
- (2019) Dandan Yin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of ceftazidime-avibactam-resistant Klebsiella pneumoniae during treatment, Finland, December 2018
- (2019) Kati Räisänen et al. Eurosurveillance
- Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018
- (2019) Yu-Lin Lee et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China
- (2019) P. Zhang et al. CLINICAL MICROBIOLOGY AND INFECTION
- Use of carbapenems in the combined treatment of emerging ceftazidime/avibactam-resistant and carbapenem-susceptible KPC-producing Klebsiella pneumoniae infections: report of a case and review of the literature
- (2019) Ángela Cano et al. Journal of Global Antimicrobial Resistance
- Resistance to Ceftazidime-Avibactam and Underlying Mechanisms
- (2019) Yuhang Wang et al. Journal of Global Antimicrobial Resistance
- Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance among Patients with Carbapenem-Resistant Enterobacteriaceae Infections
- (2018) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Meropenem-vaborbactam: a carbapenem and beta-lactamase inhibitor with activity against carbapenem-resistant Enterobacteriaceae
- (2018) Young R. Lee et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- High ceftazidime hydrolysis activity and porin OmpK35 deficiency contribute to the decreased susceptibility to ceftazidime/avibactam in KPC-producing Klebsiella pneumoniae
- (2017) Zhen Shen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China
- (2017) Rong Zhang et al. EBioMedicine
- Genomic Characterization of Enterobacter cloacae Isolates from China That Coproduce KPC-3 and NDM-1 Carbapenemases
- (2016) Hong Du et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
- (2016) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations
- (2016) David van Duin et al. CLINICAL INFECTIOUS DISEASES
- Ceftazidime-Avibactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms
- (2016) Roopali Sharma et al. CLINICAL THERAPEUTICS
- Emergence of KPC new variants (KPC-16 and KPC-17) and ongoing outbreak in southern Taiwan
- (2015) W.-L. Yu et al. CLINICAL MICROBIOLOGY AND INFECTION
- Activity of ceftazidime/avibactam against isogenic strains ofEscherichia colicontaining KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop
- (2015) Marisa L. Winkler et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Phase 1 study assessing the steady-state concentration of ceftazidime and avibactam in plasma and epithelial lining fluid following two dosing regimens
- (2015) David P. Nicolau et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study
- (2015) Mario Tumbarello et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Intrapersonal mutation of rmpA and rmpA2: A reason for negative hypermucoviscosity phenotype and low virulence of rmpA-positive Klebsiella pneumoniae isolates
- (2015) Wen-Liang Yu et al. Journal of Global Antimicrobial Resistance
- Treating infections caused by carbapenemase-producing Enterobacteriaceae
- (2014) L.S. Tzouvelekis et al. CLINICAL MICROBIOLOGY AND INFECTION
- Phenotypic and Enzymatic Comparative Analysis of the KPC Variants, KPC-2 and Its Recently Discovered Variant KPC-15
- (2014) Dongguo Wang et al. PLoS One
- Contribution of β-Lactamases and Porin Proteins OmpK35 and OmpK36 to Carbapenem Resistance in Clinical Isolates of KPC-2-Producing Klebsiella pneumoniae
- (2013) Ying Zhang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing
- (2012) Anton Bankevich et al. JOURNAL OF COMPUTATIONAL BIOLOGY
- Pharmacodynamics of β-Lactamase Inhibition by NXL104 in Combination with Ceftaroline: Examining Organisms with Multiple Types of β-Lactamases
- (2011) Arnold Louie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel KPC Variant from a Carbapenem-Resistant Strain of Klebsiella pneumoniae in a Chinese Hospital
- (2011) Jian Ming Zhu et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now